FIG vs HALO Comparison

Figma provides software solutions for design-related workflows. Since its founding in 2015, the company has introduced a variety of products and established an end-to-end platform for software design and product development. The firm's original and most important solution, Figma Design, was built as a collaborative tool to bring together designers and engineers in a real-time, multiple-simultaneous-editor workspace. Figma is headquartered in San Francisco, California, and completed its IPO in July 2025.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.